Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study

被引：0
|
作者：
Ridolfi, L.
Fiammenghi, L.
Petrini, M.
Granato, A.
Ancarani, V.
Pancisi, E.
Guidoboni, M.
Riccobon, A.
Ascierto, P. A.
Ridolfi, R.
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
[2] Ist Nazl Tumori Pascale, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS311
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations
    Petrini, M.
    Ridolfi, L.
    Fiammenghi, L.
    Napolitano, M.
    Granato, A. M.
    Ancarani, V.
    Pancisi, E.
    Guidoboni, M.
    Nicoletti, S.
    Valmorri, L.
    Riccobon, A.
    Migliori, G.
    Venanzi, F. M.
    Ascierto, P. A.
    Ridolfi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
    Oshita, Chie
    Takikawa, Masako
    Kume, Akiko
    Miyata, Haruo
    Ashizawa, Tadashi
    Iizuka, Akira
    Kiyohara, Yoshio
    Yoshikawa, Shusuke
    Tanosaki, Ryuji
    Yamazaki, Naoya
    Yamamoto, Akifumi
    Takesako, Kazutoh
    Yamaguchi, Ken
    Akiyama, Yasuto
    ONCOLOGY REPORTS, 2012, 28 (04) : 1131 - 1138
  • [3] Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2
    Bjoern, J.
    Brimnes, M. K.
    Andersen, M. H.
    Straten, P. Thor
    Svane, I. M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (03) : 222 - 233
  • [4] Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
    Ridolfi, Laura
    Petrini, Massimiliano
    Granato, Anna Maria
    Gentilcore, Giusy
    Simeone, Ester
    Ascierto, Paolo Antonio
    Pancisi, Elena
    Ancarani, Valentina
    Fiammenghi, Laura
    Guidoboni, Massimo
    de Rosa, Francesco
    Valmorri, Linda
    Scarpi, Emanuela
    Nicoletti, Stefania Vittoria Luisa
    Baravelli, Stefano
    Riccobon, Angela
    Ridolfi, Ruggero
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [5] Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
    Laura Ridolfi
    Massimiliano Petrini
    Anna Maria Granato
    Giusy Gentilcore
    Ester Simeone
    Paolo Antonio Ascierto
    Elena Pancisi
    Valentina Ancarani
    Laura Fiammenghi
    Massimo Guidoboni
    Francesco de Rosa
    Linda Valmorri
    Emanuela Scarpi
    Stefania Vittoria Luisa Nicoletti
    Stefano Baravelli
    Angela Riccobon
    Ruggero Ridolfi
    Journal of Translational Medicine, 11
  • [6] Phase II study of low-dose cyclophosphamide and ipilimumab in metastatic melanoma.
    Pavlick, Anna C.
    Chandra, Sunandana
    Stein, Claire
    Madden, Kathleen M.
    Kannan, Rajni
    Escano, Crystal
    Muren, Caroline
    Yepes, Ethel
    Sabado, Rachel Lubong
    Bhardwaj, Nina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Increase of CD4+CD25highFoxp3+ regulatory T cells in peripheral blood in patients with metastatic renal cell carcinoma treated with dendritic cell vaccination and low-dose IL-2
    Berntsen, A.
    Brimnes, M. K.
    Straten, P. T.
    Svane, I. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A phase I study of adoptive T-cell therapy with or without dendritic cell vaccination in patients with metastatic melanoma.
    Tell, Roger
    Mattson, Jonas
    Adamson, Lars
    Poschke, Isabel
    Engstrom, Mats
    Lovpren, Tanja
    Hansson, Johan
    Masuccl, Giuseppe V.
    Lundqvist, Andreas
    Kiessling, Rolf
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Phase I/II study of vaccination with immature and mature dendritic cells in patients with melanoma and renal cell carcinoma
    M Petrini
    L Fiammenghi
    L Ridolfi
    M Stefanelli
    G Migliori
    C Brolli
    A Riccobon
    R Ridolfi
    Cancer Cell International, 4 (Suppl 1)
  • [10] Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
    Lemoine, Francois M.
    Cherai, Mustapha
    Giverne, Camille
    Dimitri, Dalia
    Rosenzwajg, Michelle
    Trebeden-Negre, Helene
    Chaput, Nathalie
    Barrou, Benoit
    Thioun, Nicolas
    Gattegnio, Bernard
    Selles, Frederic
    Six, Alain
    Azar, Nabih
    Lotz, Jean Pierre
    Buzyn, Agnes
    Sibony, Mathilde
    Delcourt, Annick
    Boyer, Olivier
    Herson, Serge
    Klatzmann, David
    Lacave, Roger
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (03) : 569 - 581
12345